You can buy or sell KZIA and other stocks, options, ETFs, and crypto commission-free!
Kazia Therapeutics Ltd. engages in the pharmaceutical drug development. It involves in preclinical research confirms efficacy of cantrixil which induces cell death in chemoresistant ovarian cancer stem cells. Read More The company was founded by Graham Edmund Kelly in March 1994 and is headquartered in Sydney, Australia.
Sydney, New South Wales (NSW)
52 Week High
52 Week Low